Study of HCW9302 for Alopecia Areata
Part of Skin clinical trials.
This trial tests a new drug, HCW9302, that targets the immune system to help hair regrow in people with alopecia areata (including extensive forms like totalis or universalis). It may be an option for adults who have not responded well to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults aged 18–70 (women) or 18–60 (men) with alopecia areata (including ophiasis, totalis, or universalis forms).
- Must not have other types of hair loss (like diffuse shedding or scarring alopecia).
- Cannot have used certain immune-targeting drugs (like IL-2 analogs) or hair growth treatments (like minoxidil) recently.
- Must not have a history of diabetes, heart issues, or active infections.
- Able to use effective birth control (if of childbearing potential) and attend study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called ALD-102, given as a small shot in the scalp, to see if it helps hair grow back in people with alopecia areata. It is an early-stage trial looking at safety, how the body handles the drug, and whether it works.
This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.
This trial tests a new drug called FB102 for people with severe to very severe alopecia areata, a condition that causes at least half of scalp hair to be lost. It aims to see if the drug is safe and can help hair grow back.
This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.
This trial tests a new medication called LAD603 for people with severe to very severe alopecia areata, a condition causing significant hair loss. It aims to see if the drug can help regrow hair.
This study tests an experimental oral tablet for severe alopecia areata, a condition that causes patches of hair to fall out. The goal is to see if it can help regrow hair safely. You may be able to join if you have this type of hair loss and meet the health requirements.
Hear when a new Alopecia Areata(AA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.